Clinical Trial

Enhanced Valves Interventions and Safe AI Generated End Results

Study acronym: ENVISAGE
Recruiting
View on ClinicalTrials.gov →
Summary
This non-interventional study aims to use artificial intelligence to improve the prediction of transcatheter heart valve interventions and optimize patient outcomes. It is based on the analysis of retrospective data from various specialized centers worldwide.
Trial Details
NCT Number NCT07213531
Lead Sponsor Montreal Heart Institute
Collaborators: Centre Hospitalier Universitaire de Bordeaux, FRANCE, Materialise, Pie Medical Imaging, Clinique Pasteur Toulouse, Centre Cardiologique du Nord, Rennes University Hospital, San Raffaele University Hospital, Italy, Istituto clinico Città di Brescia, Unity Health Toronto, University Hospital, Marseille, University Hospital, Lille, Hospitaux Universitaires Paris Sud, Montefiore Medical Center, University Medical Center Mainz, Universitätsklinikum Hamburg-Eppendorf, Vancouver Hospital
Conditions Heart Valve Disease, TAVI, M-TEER, TTVI, TMVI, T-TEER, Mitraclip, TriClip
Enrollment 21,000 participants
Start Date 2024-05-01
Primary Completion 2028-05 (estimated)
Study Completion 2029-05 (estimated)
Updated on ClinicalTrials.gov 2025-10-09